Product

SPH3127+Valsartan

Aliases

SPH3127+valsartan matching placebo

1 clinical trial

1 indication

Indication

Diabetic Nephropathy

Clinical trial

A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Dose-finding Phase 2 Clinical Study to Evaluate the Efficacy and Safety of SPH3127 Tablets in the Treatment of Diabetic Kidney Disease

Status: Recruiting, Estimated PCD: 2024-09-30